Callitas Theraputics Inc., a wholly owned subsidiary of M Pharmaceutial Inc.
Board of Directors 2017-07-31T16:49:35+00:00

Board of Directors

Our Board of Directors is made up of an experienced group of individuals from a variety of industries, including healthcare, medicine, law and business

Gary A. Thompson, B.S.
Gary A. Thompson, B.S.President and CEO
30 years plus of sales and management experience in Fortune 500 health care organizations and start-up pharmaceutical companies

Served as Vice President of Sales for Cigna Healthcare, managing billions of dollars of assets over his career

Management and leadership roles with start-up ventures including ToConceive LLC., (510K FDA Clearance) in women’s health and wellness, and in the obesity space as President of Callitas’ newly acquired Chelatexx, LLC., C-103 reformulated orlistat.

Dr. Christopher Andrews, M.D., MSc, FRCPC
Dr. Christopher Andrews, M.D., MSc, FRCPCDirector
Gastroenterologist, faculty member of the Department of Medicine at the University of Calgary and graduate of the Mayo Clinic in Rochester, MN

Specialist in stomach disorders and physiology, with advanced training in gastrointestinal motility and function

Master’s Degree in Clinical Health Research from the Mayo Clinic

D. Richard Skeith, BA/JD
D. Richard Skeith, BA/JDDirector
BA (Hons) in Economics, University of Alberta; JD Faculty of Law, University of Alberta

Practicing lawyer with specialized focus on publicly traded companies

Broad experience as an Officer or Director of multiple public companies in sectors including pharmaceuticals, mining, oil and gas, and real estate

Kim E. Whittemore, B.S.
Kim E. Whittemore, B.S.Management Consultant
University of Pennsylvania International Relations graduate, completed MIT executive courses in Computer Science and has an advanced certificate in digital marketing

Held senior executive positions with DecisionOne Corporation, Verizon and AT&T after beginning her career at the National Security Agency (NSA)

Vast experience in the fields of digital health, wearable tech and women’s health, and works with clients on business strategy and digital marketing through her management consulting practice

William A. Rodgers, Jr., B.S.
William A. Rodgers, Jr., B.S.President and CEO of Four 12 Solutions
Senior executive management background with both publicly traded and private equity backed businesses. Key expertise with acquisition and start up activities, leading the expansion of businesses and new market entry.

Held several Senior Executive level positions at Fortune 150 Corporations, including Waste Management, Inc., Johnson Controls, Inc. and EMCOR Group.

Former President and Chief Executive Officer for GoodCents Holdings, Inc. and currently CEO and President of Four 12 Solutions assisting companies achieve aggressive growth objectives and enhancing operational effectiveness.